Correlation Between Intracellular and Cyclo Therapeutics
Can any of the company-specific risk be diversified away by investing in both Intracellular and Cyclo Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Intracellular and Cyclo Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Intracellular Th and Cyclo Therapeutics, you can compare the effects of market volatilities on Intracellular and Cyclo Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Intracellular with a short position of Cyclo Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Intracellular and Cyclo Therapeutics.
Diversification Opportunities for Intracellular and Cyclo Therapeutics
0.52 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Intracellular and Cyclo is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding Intracellular Th and Cyclo Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cyclo Therapeutics and Intracellular is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Intracellular Th are associated (or correlated) with Cyclo Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cyclo Therapeutics has no effect on the direction of Intracellular i.e., Intracellular and Cyclo Therapeutics go up and down completely randomly.
Pair Corralation between Intracellular and Cyclo Therapeutics
Given the investment horizon of 90 days Intracellular Th is expected to generate 0.11 times more return on investment than Cyclo Therapeutics. However, Intracellular Th is 9.18 times less risky than Cyclo Therapeutics. It trades about 0.23 of its potential returns per unit of risk. Cyclo Therapeutics is currently generating about -0.24 per unit of risk. If you would invest 12,797 in Intracellular Th on December 14, 2024 and sell it today you would earn a total of 339.00 from holding Intracellular Th or generate 2.65% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Intracellular Th vs. Cyclo Therapeutics
Performance |
| Timeline |
| Intracellular Th |
| Cyclo Therapeutics |
Intracellular and Cyclo Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Intracellular and Cyclo Therapeutics
The main advantage of trading using opposite Intracellular and Cyclo Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Intracellular position performs unexpectedly, Cyclo Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cyclo Therapeutics will offset losses from the drop in Cyclo Therapeutics' long position.| Intracellular vs. Alkermes Plc | ||
| Intracellular vs. Ironwood Pharmaceuticals | ||
| Intracellular vs. Pacira BioSciences, | ||
| Intracellular vs. Collegium Pharmaceutical |
| Cyclo Therapeutics vs. Lifecore Biomedical | ||
| Cyclo Therapeutics vs. Alpha Teknova | ||
| Cyclo Therapeutics vs. Petros Pharmaceuticals | ||
| Cyclo Therapeutics vs. Phibro Animal Health |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Other Complementary Tools
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| CEOs Directory Screen CEOs from public companies around the world |